Invokana Reported to Pose Greater Risk of Developing Yeast Infections

Not only has type-2 diabetes drug Invokana been associated with kidney problems and high blood-acidity levels that can lead to hospitalization, the medication also may pose another risk: an increased risk of recurring infections, including yeast infections.  According to Dr. John Sink of Jones Center for Diabetes and Endocrine Wellness, nearly 10% of patients taking Invokana will develop a mycotic infection or urinary tract infection. “You have to have this conversation with men just as much as you do with women,” Sink explained, adding that nearly 20% of patients on the drug will likely experience recurring infections.

Real Time Analytics